WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+2.4%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.81B
AUM Growth
+$6.81B
(+11%)
Cap. Flow
+$637M
Cap. Flow
% of AUM
9.35%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
980
New
186
Increased
207
Reduced
145
Closed
238
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$129M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$92.7M |
| 4 |
Amazon
AMZN
|
$77.2M |
| 5 |
Analog Devices
ADI
|
$70.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$74.7M |
| 2 |
Palo Alto Networks
PANW
|
$59.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$55.4M |
| 4 |
Alkermes
ALKS
|
$55.3M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$53.9M |
Sector Composition
| 1 | Healthcare | 37.87% |
| 2 | Technology | 30.7% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.09% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $144M | 2.01% | 2,326,663 +2,088,635 | +877% | +$129M |
|
|
2
Gilead Sciences
GILD
$140B
| $140M | 1.95% | 2,262,691 +1,844,728 | +441% | +$114M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $129M | 1.8% | 187,357 +134,565 | +255% | +$92.7M |
|
|
4
Eli Lilly
LLY
$657B
| $85.7M | 1.2% | 265,099 -230,904 | -47% | -$74.7M |
|
5
Merck
MRK
$210B
| $84.3M | 1.18% | 978,487 +412,503 | +73% | +$35.5M |
|
|
6
Amazon
AMZN
$2.44T
| $77.2M | 1.08% | +683,398 | New | +$77.2M |
|
7
Medtronic
MDT
$119B
| $76.3M | 1.07% | 944,872 +367,291 | +64% | +$29.7M |
|
|
8
Analog Devices
ADI
$124B
| $70.5M | 0.98% | +505,773 | New | +$70.5M |
|
9
Teradyne
TER
$18.8B
| $67.2M | 0.94% | 893,762 +716,124 | +403% | +$53.8M |
|
10
STMicroelectronics
STM
$24.1B
| $63.5M | 0.89% | 2,051,114 -1,121,002 | -35% | -$34.7M |
|
11
L3Harris
LHX
$51.9B
| $63.4M | 0.89% | 305,160 +156,937 | +106% | +$32.6M |
|
12
Huntington Ingalls Industries
HII
$10.6B
| $61.1M | 0.85% | 276,006 +76,585 | +38% | +$17M |
|
13
HCA Healthcare
HCA
$94.5B
| $60M | 0.84% | +326,514 | New | +$60M |
|
14
Meta Platforms (Facebook)
META
$1.86T
| $57.6M | 0.81% | +424,832 | New | +$57.6M |
|
15
Vishay Intertechnology
VSH
$2.1B
| $54.5M | 0.76% | 3,061,528 +365,637 | +14% | +$6.5M |
|
16
Cigna
CI
$80.3B
| $54.4M | 0.76% | 196,138 +122,240 | +165% | +$33.9M |
|
17
Arrow Electronics
ARW
$6.51B
| $54.3M | 0.76% | 588,896 -40,476 | -6% | -$3.73M |
|
18
Skyworks Solutions
SWKS
$11.1B
| $54M | 0.76% | 633,683 -321,977 | -34% | -$27.5M |
|
19
Dell
DELL
$82.6B
| $53.2M | 0.74% | 1,556,741 +1,084,642 | +230% | +$37.1M |
|
20
Viavi Solutions
VIAV
$2.52B
| $52.8M | 0.74% | 4,046,643 +1,967,867 | +95% | +$25.7M |
|
21
Danaher
DHR
$147B
| $51.1M | 0.71% | +197,749 | New | +$51.1M |
|
22
Leidos
LDOS
$23.2B
| $49.7M | 0.69% | +567,768 | New | +$49.7M |
|
23
ASML
ASML
$292B
| $49.5M | 0.69% | 119,204 -9,138 | -7% | -$3.8M |
|
24
Boston Scientific
BSX
$156B
| $49M | 0.68% | 1,265,340 -996,652 | -44% | -$38.6M |
|
25
Allogene Therapeutics
ALLO
$251M
| $48.9M | 0.68% | 4,526,422 -1,333,257 | -23% | -$14.4M |
|